Leukogene Therapeutics
PrivateLast Round
Seed
Nov 12, 2025
Total Funding Raised
$2.63M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Leukogene Therapeutics is a biopharmaceutical company developing MHC class II-targeted recombinant protein immunotherapies to treat hematologic and other immunologically “cold” cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Leukogene Therapeutics Comparables
Compare Leukogene Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Asylia Therapeutics | 82% | |
| Amgen | 71% | |
| Johnson & Johnson | 69% |
Leukogene Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Nov 12, 2025 | ||||
| Seed | Sep 9, 2025 | ||||
| Grant | Aug 30, 2018 |
Key People
Founding team and executive leadership
Leukogene Therapeutics Investors
Notable investors and investment history
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 9, 2025
Raised Seed round with participation from 1824healthventures.
- Aug 30, 2018
Raised $2M in grant funding.
Leukogene Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Leukogene Therapeutics's valuation, stock price, and market status.
Is Leukogene Therapeutics a public or private company?
Leukogene Therapeutics is a private company.
What is the current stock price of Leukogene Therapeutics?
Leukogene Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Leukogene Therapeutics worth (valuation)?
Valuation information for Leukogene Therapeutics is not publicly available.
Can I buy Leukogene Therapeutics stock?
Leukogene Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Leukogene Therapeutics's last funding round?
Leukogene Therapeutics's most recent funding round was Seed on November 12, 2025.
Who are the main investors in Leukogene Therapeutics?
Key investors in Leukogene Therapeutics include SC Launch, SCRA.
Will Leukogene Therapeutics IPO soon?
No public IPO plans have been announced for Leukogene Therapeutics.
How can I track Leukogene Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Leukogene Therapeutics's secondary market activity and sign up for updates.